Search
Novo Holdings, Parent Entity of Novo Nordisk, Pours Capital into Launching the Globe's Biggest Quantum-Focused Venture Capital Fund
2 day ago /
Read about 0 minute
Author：小编
Recently, Novo Holdings, the parent company of the Danish pharmaceutical behemoth Novo Nordisk (the maker of the weight - loss medication semaglutide), made an investment to set up the quantum - dedicated venture capital fund, 55 North. During its inaugural funding round, the fund managed to amass around €300 million. Novo Holdings and the Danish Export and Investment Fund (EIFO) took on the role of cornerstone investors, jointly pumping in €134 million. At present, this fund holds the title of being the world's largest venture capital fund specifically aimed at the quantum sector.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
